Silver Creek’s stroke hopeful yields mixed results in Phase II trial

If approved, the targeted IGF-1 fusion protein would become the only treatment available for late-window stroke patients ...

Silver Creek Pharmaceuticals Announces Positive Phase 2 Results for Scp776 in Acute Ischemic Stroke

Key Highlights Scp776 is the first therapy to show clinically meaningful efficacy in late-window stroke patients (treated up ...
The Malaysian Reserve

Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executi…

Financing supports execution of Phase 2b RAISE trial evaluating BB-031, an investigational reversible thrombolytic for acute ...
IEEE

A Universal Scale-Adaptive Deformable Transformer for Image Restoration across Diverse Artifacts

Abstract: Structured artifacts are semi-regular, repetitive patterns that closely intertwine with genuine image content, making their removal highly challenging. In this paper, we introduce the ...